Pressure BioSciences announced the Company’s strategic decision to offer up to five exclusive licenses to their patented and powerful UltraShear Technology platform for the processing of oil-soluble THC concentrates in water into long-term stable, effectively water-soluble, and highly bioavailable nanoemulsions. PBI is offering a limited number of 3-year, exclusive, statewide licenses to their patented UltraShear technology platform for preparing THC nanoemulsions. Processing equipment will be custom-manufactured for each Licensee. Each exclusive license will be for a single US state. The Licensee will pay an up-front license fee plus the cost to build the custom BaroShear equipment that will be placed in their facility. The resulting BaroShear equipment will be under a no-cost 3-year lease. Following the initial lease period, each Licensee will have a first opportunity right to negotiate an extension to their exclusive license. The Company plans to offer a broad-based "lease and license" program for the BaroShear equipment for THC applications on a non-exclusive basis in approximately two years. When available, no BaroShear systems will be offered for THC processing in any state that has already been designated "Exclusive" through the Early Access Program.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PBIO:
- Pressure BioSciences, Artisan Industries enter strategic agreement
- Pressure BioSciences’ PBI Agrochem ships, bills initial $130,000 order
- Pressure BioSciences receives $1.5M contract for UltraShear CBD
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue